BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17043621)

  • 1. Comparison of a beta-blocker and an If current inhibitor in rabbits with myocardial infarction.
    Langenbach MR; Schmitz-Spanke S; Brockert M; Schepan M; Pomblum VJ; Gams E; Zirngibl H; Schipke JD
    J Cardiovasc Surg (Torino); 2006 Dec; 47(6):719-25. PubMed ID: 17043621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmyocardial infarction remodeling and coronary reserve: effects of ivabradine and beta blockade therapy.
    Christensen LP; Zhang RL; Zheng W; Campanelli JJ; Dedkov EI; Weiss RM; Tomanek RJ
    Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H322-30. PubMed ID: 19411283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: preliminary findings.
    Fasullo S; Cannizzaro S; Maringhini G; Ganci F; Giambanco F; Vitale G; Pinto V; Migliore G; Torres D; Sarullo FM; Paterna S; Di Pasquale P
    J Card Fail; 2009 Dec; 15(10):856-63. PubMed ID: 19944362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
    Maczewski M; Mackiewicz U
    Cardiovasc Res; 2008 Jul; 79(1):42-51. PubMed ID: 18310678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects on isolated hearts with developing infarction: slow channel blockade by diltiazem versus beta-adrenoceptor antagonism by metoprolol.
    Hamm CW; Thandroyen FT; Opie LH
    Am J Cardiol; 1982 Oct; 50(4):857-63. PubMed ID: 6127029
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
    Gerbaud E; Montaudon M; Chasseriaud W; Gilbert S; Cochet H; Pucheu Y; Horovitz A; Bonnet J; Douard H; Coste P
    Arch Cardiovasc Dis; 2014 Jan; 107(1):33-41. PubMed ID: 24440004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivabradine vs metoprolol in patients with acute inferior wall myocardial infarction-"Expanding arena for ivabradine".
    Priti K; Ranwa BL; Gokhroo RK; Kishore K; Bisht DS; Gupta S
    Cardiovasc Ther; 2017 Aug; 35(4):. PubMed ID: 28423233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of metoprolol on ventricular relaxation in experimental myocardial infarction].
    Meaney-Mendiolea E; Shuchleib-Chaba R; Jaurés-Arce V; Chousleb-Kalach A; Vela-Huerta A; Samaniego-Méndez V
    Gac Med Mex; 1998; 134(6):661-7. PubMed ID: 9927772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium-hydrogen exchange inhibition and beta-blockade additively decrease infarct size.
    Wang P; Zaragoza C; Holman W
    Ann Thorac Surg; 2007 Mar; 83(3):1121-7. PubMed ID: 17307470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working hearts.
    Lauzier B; Vaillant F; Gélinas R; Bouchard B; Brownsey R; Thorin E; Tardif JC; Des Rosiers C
    Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H845-52. PubMed ID: 21257916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart Rate Reduction With Ivabradine Protects Against Left Ventricular Remodeling by Attenuating Infarct Expansion and Preserving Remote-Zone Contractile Function and Synchrony in a Mouse Model of Reperfused Myocardial Infarction.
    O'Connor DM; Smith RS; Piras BA; Beyers RJ; Lin D; Hossack JA; French BA
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27107133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the pacemaker current: a bradycardic therapy for off-pump coronary operations.
    Bel A; Perrault LP; Faris B; Mouas C; Vilaine JP; Menasché P
    Ann Thorac Surg; 1998 Jul; 66(1):148-52. PubMed ID: 9692455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction.
    Heusch G; Skyschally A; Gres P; van Caster P; Schilawa D; Schulz R
    Eur Heart J; 2008 Sep; 29(18):2265-75. PubMed ID: 18621770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Chronic Heart Rate Reduction by I(f) Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure.
    Dedkov EI; Bogatyryov Y; McCooey DS; Christensen LP; Weiss RM; Tomanek RJ
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):299-312. PubMed ID: 25287895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic heart rate reduction facilitates cardiomyocyte survival after myocardial infarction.
    Zhang RL; Christensen LP; Tomanek RJ
    Anat Rec (Hoboken); 2010 May; 293(5):839-48. PubMed ID: 20225200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats.
    Sun YL; Hu SJ; Wang LH; Hu Y; Zhou JY
    Chest; 2005 Sep; 128(3):1812-21. PubMed ID: 16162791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
    Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.